Garry Menzel
Director/Board Member bei ADAPTIMMUNE THERAPEUTICS PLC
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Garry Menzel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 01.01.2014 | - |
Independent Dir/Board Member | 01.01.2014 | - | |
STOKE THERAPEUTICS, INC. | Director/Board Member | 13.08.2020 | - |
Independent Dir/Board Member | 13.08.2020 | - | |
ADAPTIMMUNE THERAPEUTICS PLC | Director/Board Member | 01.06.2023 | - |
Independent Dir/Board Member | 01.06.2023 | - | |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Corporate Officer/Principal | 01.01.2003 | - |
Epilepsy Therapy Project | Director/Board Member | - | - |
Royal College of Art | Corporate Officer/Principal | 17.03.2010 | - |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 23.04.2024 | - |
Karriereverlauf von Garry Menzel
Ehemalige bekannte Positionen von Garry Menzel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TCR2 THERAPEUTICS INC. | Director/Board Member | 01.01.2016 | - |
Chief Executive Officer | 01.01.2016 | 01.01.2023 | |
President | 01.01.2016 | - | |
AXCA HEALPAR | Corporate Officer/Principal | 01.07.2015 | 01.09.2016 |
░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Garry Menzel
Imperial College London | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 13 |
Vereinigtes Königreich | 7 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 7 |
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 8 |
Consumer Services | 5 |
Finance | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 7 |
---|---|
DAVITA INC. | Health Services |
THE GOLDMAN SACHS GROUP, INC. | Finance |
REGULUS THERAPEUTICS INC. | Health Technology |
AXCA HEALPAR | Health Technology |
STOKE THERAPEUTICS, INC. | Health Technology |
BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 8 |
---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Credit Suisse Group AG
Credit Suisse Group AG Investment Banks/BrokersFinance Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse’s Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headquartered in Zurich, Switzerland. | Finance |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA. | Commercial Services |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Commercial Services |
Epilepsy Therapy Project | |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Finance |
- Börse
- Insiders
- Garry Menzel
- Erfahrung